JB Chemicals & Pharmaceuticals today reported a 7.23 per cent rise in its standalone net profit to Rs 45.19 crore for the quarter ended September 30, mainly on account of robust domestic formulations sales.
The company had posted a net profit of Rs 42.14 crore during the same period a year ago, JB Chemicals & Pharmaceuticals said in a filing to BSE.
The company's total income from operations also rose to Rs 301.48 crore during the quarter under review as against Rs 291.01 crore in the year-ago period.
In another filing, the company said its board of directors has appointed Manoj R Mashru as additional director of the company. He is an independent director on the board.
He will hold the office of additional director to the date of next Annual General Meeting (AGM), it added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
